Educational content on VJHemOnc is intended for healthcare professionals only. By visiting this website and accessing this information you confirm that you are a healthcare professional.

Share this video  

ASH 2023 | The increased risk of thromboembolism in cancer

Orly Leiva • 9 Dec 2023
ASH 2023
General

Orly Leiva, MD, NYU Langone Health, New York City, NY, discusses the increased risk of venous thromboembolism in patients with cancer. Cancer impacts all three aspects of Virchow’s triad (blood coagulation, flow, and endothelial damage) and predisposes an individual to vascular thrombosis. Dr Leiva highlights that this increased risk should not be ignored when conducting cancer studies. This interview took place at the 65th ASH Annual Meeting and Exposition, held in San Diego, CA.

These works are owned by Magdalen Medical Publishing (MMP) and are protected by copyright laws and treaties around the world. All rights are reserved.

More from Orly Leiva

1:21
Cardio-oncology: an emerging field within cancer treatment
Orly Leiva • 9 Dec 2023
1:21
Cardiovascular disease is associated with poorer outcomes in patients with MPNs
Orly Leiva • 9 Dec 2023
1:38
The risk of bleeding in patients with von Willebrand disease hospitalized due to AMI
Orly Leiva • 9 Dec 2023
1:53
The risk of heart failure in MPNs and the rate of CV-related readmissions following heart failure
Orly Leiva • 9 Dec 2023

Related Videos

4:33
The EBMT Patient Advocacy Committee: Patient, Family and Donor Day at EBMT 2024
Natacha Bolaños • 16 Apr 2024
2:55
Distinguishing late-onset neutropenia from classical primary neutropenia
Carlo Dufour • 15 Apr 2024
2:39
The MAGIC algorithm probability to predict outcomes of GvHD in the GI tract
James Ferrara • 16 Apr 2024
2:25
The EBMT Trainee Committee: in-person trainee day at EBMT 2024 and upcoming initiatives
Claire Horgan • 15 Apr 2024
The content of VJHemOnc is intended for healthcare professionals